{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:41:58Z","timestamp":1793911318864,"version":"4.8.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 81970434"],"award-info":[{"award-number":["No. 81970434"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Multisystem inflammatory syndrome in children (MIS-C) is a new syndrome with some clinical manifestations similar to Kawasaki disease (KD), which is difficult to distinguish.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>The study aimed to characterize the demographic characteristics, clinical characteristics, laboratory features, cardiac complications, and treatment of MIS-C compared with KD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Study design<\/jats:title>\n                <jats:p>Studies were selected by searching the PubMed, EMBASE and so on before February 28, 2022. Statistical analyses were performed using Review Manager 5.4 software and STATA 14.0.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Fourteen studies with 2928 participants were included. MIS-C patients tended to be older and there was no significant difference in the sex ratio. In terms of clinical characteristics, MIS-C patients were more frequently represented with respiratory, gastrointestinal symptoms and shock. At the same time, they had a lower incidence of conjunctivitis than KD patients. MIS-C patients had lower lymphocyte counts, platelet (PLT) counts, erythrocyte sedimentation rates (ESRs), alanine transaminase (ALT), and albumin levels and had higher levels of aspartate transaminase (AST), N-terminal pro-B-type natriuretic peptide (NT-pro-BNP), troponin, C-reactive protein (CRP), D-dimer, fibrinogen, ferritin, and creatinine. MIS-C patients had a higher incidence of left ventricle (LV) dysfunction, valvular regurgitation, pericardial effusion, myocarditis, and pericarditis. The incidence of coronary artery lesion (CAL) was lower in MIS-C patients [OR (95% CI): 0.52 (0.29, 0.93), <jats:italic>p<\/jats:italic> =0.03], while it was similar in the acute period. MIS-C patients had higher utilization of glucocorticoids (GCs) and lower utilization of intravenous immune globulin (IVIG).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>There were specific differences between MIS-C and KD, which might assist clinicians with the accurate recognition of MIS-C and further mechanistic research.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12969-022-00771-x","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T07:03:04Z","timestamp":1670223784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Similarities and differences between MIS-C and KD: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"20","author":[{"given":"Tong","family":"Tong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijing","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songling","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8925-5904","authenticated-orcid":false,"given":"Fangqi","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,5]]},"reference":[{"key":"771_CR1","doi-asserted-by":"publisher","unstructured":"Verdoni L, Mazza A. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020. https:\/\/doi.org\/10.1016\/s0140-6736(20)31103-x.","DOI":"10.1016\/s0140-6736(20)31103-x"},{"key":"771_CR2","doi-asserted-by":"publisher","unstructured":"McCrindle BW, Rowley AH. Diagnosis, treatment, and long-term management of Kawasaki Disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017. https:\/\/doi.org\/10.1161\/cir.0000000000000484.","DOI":"10.1161\/cir.0000000000000484"},{"key":"771_CR3","doi-asserted-by":"publisher","unstructured":"Castagnoli R, Votto M. Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review. JAMA Pediatr. 2020. https:\/\/doi.org\/10.1001\/jamapediatrics.2020.1467.","DOI":"10.1001\/jamapediatrics.2020.1467"},{"key":"771_CR4","unstructured":"Royal College of Pediatrics and Child Health. Guidance - COVID-19 paediatric multisystem inflammatory syndrome. 2020. Available from: https:\/\/www.rcpch.ac.uk\/resources\/guidance-paediatric-multisystem-inflammatory-syndrome-temporally-associated-covid-19.\u00a0Accessed 22 May 2020."},{"key":"771_CR5","unstructured":"Centers for Disease Control and Prevention. Emergency preparedness and response: health alert network. Published May 14, 2020. Accessed 22 May 2020. Available from: https:\/\/emergency.cdc.gov\/han\/2020\/han00432.asp"},{"key":"771_CR6","unstructured":"World Health Organization. Multisystem inflammatory syndrome in children and adolescents with COVID-19. Published May 15, 2020. Accessed 22 May 2020. Available from:https:\/\/www.who.int\/publications-detail\/multisystem-inflammatory-syndrome-in-children-and-adolescents-with- covid-19"},{"key":"771_CR7","doi-asserted-by":"publisher","unstructured":"Nakra NA, Blumberg DA. Multi-System Inflammatory Syndrome in Children (MIS-C) following sars-cov-2 infection: review of clinical presentation, hypothetical pathogenesis, and proposed management. Children (Basel). 2020. https:\/\/doi.org\/10.3390\/children7070069.","DOI":"10.3390\/children7070069"},{"key":"771_CR8","doi-asserted-by":"publisher","unstructured":"Booth A, Clarke M. The nuts and bolts of PROSPERO: an international prospective register of systematic reviews. Syst Rev. 2012. https:\/\/doi.org\/10.1186\/2046-4053-1-2.","DOI":"10.1186\/2046-4053-1-2"},{"key":"771_CR9","doi-asserted-by":"publisher","unstructured":"Cook DA, Reed DA. Appraising the quality of medical education research methods: the Medical Education Research Study Quality Instrument and the Newcastle-Ottawa Scale-Education. Acad Med. 2015. https:\/\/doi.org\/10.1097\/acm.0000000000000786.","DOI":"10.1097\/acm.0000000000000786"},{"key":"771_CR10","doi-asserted-by":"publisher","unstructured":"Carbajal R, Lorrot M. Multisystem inflammatory syndrome in children rose and fell with the first wave of the COVID-19 pandemic in France. Acta Paediatr. 2021. https:\/\/doi.org\/10.1111\/apa.15667.","DOI":"10.1111\/apa.15667"},{"key":"771_CR11","doi-asserted-by":"publisher","unstructured":"Whittaker E, Bamford A. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA. 2020. https:\/\/doi.org\/10.1001\/jama.2020.10369.","DOI":"10.1001\/jama.2020.10369"},{"key":"771_CR12","doi-asserted-by":"publisher","unstructured":"Mohsin SS, Abbas Q. Multisystem inflammatory syndrome (MIS-C) in Pakistani children: A description of the phenotypes and comparison with historical cohorts of children with Kawasaki disease and myocarditis. PLoS One. 2021. https:\/\/doi.org\/10.1371\/journal.pone.0253625.","DOI":"10.1371\/journal.pone.0253625"},{"key":"771_CR13","doi-asserted-by":"publisher","unstructured":"Matsubara D, Kauffman HL. Echocardiographic findings in pediatric multisystem inflammatory syndrome associated with COVID-19 in the United States. J Am Coll Cardiol. 2020. https:\/\/doi.org\/10.1016\/j.jacc.2020.08.056.","DOI":"10.1016\/j.jacc.2020.08.056"},{"key":"771_CR14","doi-asserted-by":"publisher","unstructured":"Lee PY, Day-Lewis M. Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children. J Clin Invest. 2020. https:\/\/doi.org\/10.1172\/jci141113.","DOI":"10.1172\/jci141113"},{"key":"771_CR15","doi-asserted-by":"publisher","unstructured":"Kostik MM, Bregel LV. Distinguishing between multisystem inflammatory syndrome, associated with covid-19 in children and the kawasaki disease: development of preliminary criteria based on the data of the retrospective multicenter cohort study. Front Pediatr. 2021. https:\/\/doi.org\/10.3389\/fped.2021.787353.","DOI":"10.3389\/fped.2021.787353"},{"key":"771_CR16","doi-asserted-by":"publisher","unstructured":"Godfred-Cato S, Abrams JY. Distinguishing multisystem inflammatory syndrome in children from COVID-19, Kawasaki Disease and toxic shock syndrome. Pediatr Infect Dis J. 2022. https:\/\/doi.org\/10.1097\/INF.0000000000003449.","DOI":"10.1097\/INF.0000000000003449"},{"key":"771_CR17","doi-asserted-by":"publisher","unstructured":"Gaitonde M, Ziebell D. COVID-19-related multisystem inflammatory syndrome in children affects left ventricular function and global strain compared with Kawasaki Disease. J Am Soc Echocardiogr. 2020. https:\/\/doi.org\/10.1016\/j.echo.2020.07.019.","DOI":"10.1016\/j.echo.2020.07.019"},{"key":"771_CR18","doi-asserted-by":"publisher","unstructured":"Felsenstein S, Duong P. Cardiac pathology and outcomes vary between Kawasaki disease and PIMS-TS. Clin Immunol. 2021. https:\/\/doi.org\/10.1016\/j.clim.2021.108780.","DOI":"10.1016\/j.clim.2021.108780"},{"key":"771_CR19","doi-asserted-by":"publisher","unstructured":"Esteve-Sole A, Anton J. Similarities and differences between the immunopathogenesis of COVID-19-related pediatric multisystem inflammatory syndrome and Kawasaki disease. J Clin Investig. 2021. https:\/\/doi.org\/10.1172\/JCI144554.","DOI":"10.1172\/JCI144554"},{"key":"771_CR20","doi-asserted-by":"publisher","unstructured":"Consiglio CR, Cotugno N. The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19. Cell. 2020. https:\/\/doi.org\/10.1016\/j.cell.2020.09.016.","DOI":"10.1016\/j.cell.2020.09.016"},{"key":"771_CR21","doi-asserted-by":"publisher","unstructured":"Cattalini M, Della Paolera S. Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey. Pediatr Rheumatol Online J. 2021. https:\/\/doi.org\/10.1186\/s12969-021-00511-7.","DOI":"10.1186\/s12969-021-00511-7"},{"key":"771_CR22","doi-asserted-by":"publisher","unstructured":"Cherqaoui B, Kon\u00e9-Paut I. Delineating phenotypes of Kawasaki disease and SARS-CoV-2-related inflammatory multisystem syndrome: a French study and literature review. Rheumatology (Oxford). 2021. https:\/\/doi.org\/10.1093\/rheumatology\/keab026.","DOI":"10.1093\/rheumatology\/keab026"},{"key":"771_CR23","doi-asserted-by":"publisher","unstructured":"Corwin DJ, Sartori LF. Distinguishing multisystem inflammatory syndrome in children from kawasaki disease and benign inflammatory illnesses in the SARS-CoV-2 Pandemic. Pediatr Emerg Care. 2020. https:\/\/doi.org\/10.1097\/pec.0000000000002248.","DOI":"10.1097\/pec.0000000000002248"},{"key":"771_CR24","doi-asserted-by":"publisher","unstructured":"Lu X, Zhang L. SARS-CoV-2 infection in children. N Engl J Med. 2020. https:\/\/doi.org\/10.1056\/NEJMc2005073.","DOI":"10.1056\/NEJMc2005073"},{"key":"771_CR25","doi-asserted-by":"publisher","unstructured":"Ravelli A, Martini A. Kawasaki disease or Kawasaki syndrome? Ann Rheum Dis. 2020. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218110.","DOI":"10.1136\/annrheumdis-2020-218110"},{"key":"771_CR26","doi-asserted-by":"publisher","unstructured":"Liu X, Zhou K. Neurological involvement in Kawasaki disease: a retrospective study. Pediatr Rheumatol Online J. 2020. https:\/\/doi.org\/10.1186\/s12969-020-00452-7.","DOI":"10.1186\/s12969-020-00452-7"},{"key":"771_CR27","doi-asserted-by":"publisher","unstructured":"Alsaied T, Tremoulet AH. Review of cardiac involvement in multisystem inflammatory syndrome in children. Circulation. 2021. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.049836.","DOI":"10.1161\/CIRCULATIONAHA.120.049836"},{"key":"771_CR28","doi-asserted-by":"publisher","unstructured":"Fabi M, Filice E. Multisystem inflammatory syndrome following sars-cov-2 infection in children: One year after the onset of the pandemic in a high-incidence area. Viruses. 2021. https:\/\/doi.org\/10.3390\/v13102022.","DOI":"10.3390\/v13102022"},{"key":"771_CR29","doi-asserted-by":"publisher","unstructured":"Hokibara S, Kobayashi N. Markedly elevated CD64 expression on neutrophils and monocytes as a biomarker for diagnosis and therapy assessment in Kawasaki disease. Inflamm Res. 2016. https:\/\/doi.org\/10.1007\/s00011-016-0942-1.","DOI":"10.1007\/s00011-016-0942-1"},{"key":"771_CR30","doi-asserted-by":"publisher","unstructured":"Orenstein JM, Shulman ST. Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study. PLoS One. 2012. https:\/\/doi.org\/10.1371\/journal.pone.0038998.","DOI":"10.1371\/journal.pone.0038998"},{"key":"771_CR31","doi-asserted-by":"publisher","unstructured":"Dolhnikoff M, Ferreira Ferranti J. SARS-CoV-2 in cardiac tissue of a child with COVID-19-related multisystem inflammatory syndrome. Lancet Child Adolesc Health. 2020. https:\/\/doi.org\/10.1016\/s2352-4642(20)30257-1.","DOI":"10.1016\/s2352-4642(20)30257-1"},{"key":"771_CR32","doi-asserted-by":"publisher","unstructured":"Bonnet M, Champagnac A. Endomyocardial biopsy findings in Kawasaki-like disease associated with SARS-CoV-2. Eur Heart J. 2020. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa588.","DOI":"10.1093\/eurheartj\/ehaa588"},{"key":"771_CR33","doi-asserted-by":"publisher","unstructured":"Capone CA, Subramony A. Characteristics, cardiac involvement, and outcomes of multisystem inflammatory syndrome of childhood associated with severe acute respiratory syndrome coronavirus 2 Infection. J Pediatr. 2020. https:\/\/doi.org\/10.1016\/j.jpeds.2020.06.044.","DOI":"10.1016\/j.jpeds.2020.06.044"},{"key":"771_CR34","doi-asserted-by":"publisher","unstructured":"Diao B, Wang C. Reduction and functional exhaustion of t cells in patients with Coronavirus Disease 2019 (COVID-19). Front Immunol. 2020. https:\/\/doi.org\/10.3389\/fimmu.2020.00827.","DOI":"10.3389\/fimmu.2020.00827"},{"key":"771_CR35","doi-asserted-by":"publisher","unstructured":"Menikou S, Langford PR. Kawasaki disease: the role of immune complexes revisited. Front Immunol. 2019. https:\/\/doi.org\/10.3389\/fimmu.2019.01156.","DOI":"10.3389\/fimmu.2019.01156"},{"key":"771_CR36","doi-asserted-by":"publisher","unstructured":"Yeo WS, Ng QX. Distinguishing between typical Kawasaki disease and multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2. Med Hypotheses. 2020. https:\/\/doi.org\/10.1016\/j.mehy.2020.110263.","DOI":"10.1016\/j.mehy.2020.110263"},{"key":"771_CR37","doi-asserted-by":"publisher","unstructured":"Tang N, Bai H. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020. https:\/\/doi.org\/10.1111\/jth.14817.","DOI":"10.1111\/jth.14817"},{"key":"771_CR38","doi-asserted-by":"publisher","unstructured":"Belhadjer Z, M\u00e9ot M. Acute heart failure in multisystem inflammatory syndrome in children in the context of global sars-cov-2 pandemic. Circulation. 2020. https:\/\/doi.org\/10.1161\/circulationaha.120.048360.","DOI":"10.1161\/circulationaha.120.048360"},{"key":"771_CR39","doi-asserted-by":"publisher","unstructured":"Kao CH, Hsieh KS. The detection of ventricular dysfunction and carditis in children with Kawasaki disease using equilibrium multigated blood pooling ventriculography and 99Tcm-HMPAO-labelled WBC heart scans. Nucl Med Commun. 1993. https:\/\/doi.org\/10.1097\/00006231-199307000-00004.","DOI":"10.1097\/00006231-199307000-00004"},{"key":"771_CR40","doi-asserted-by":"publisher","unstructured":"Feldstein LR, Rose EB. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents. N Engl J Med. 2020. https:\/\/doi.org\/10.1056\/NEJMoa2021680.","DOI":"10.1056\/NEJMoa2021680"},{"key":"771_CR41","doi-asserted-by":"publisher","unstructured":"Henderson LA, Canna SW. American college of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 2. Arthritis Rheumatol. 2021. https:\/\/doi.org\/10.1002\/art.41616.","DOI":"10.1002\/art.41616"},{"key":"771_CR42","doi-asserted-by":"publisher","unstructured":"Felsenstein S, Willis E. Presentation, treatment response and short-term outcomes in paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 (PIMS-TS). J Clin Med. 2020. https:\/\/doi.org\/10.3390\/jcm9103293.","DOI":"10.3390\/jcm9103293"},{"key":"771_CR43","doi-asserted-by":"publisher","unstructured":"Tran VL, Parsons S. The trilogy of SARS-CoV-2 in pediatrics (Part 3): Thrombosis, anticoagulant, and antiplatelet considerations. J Pediatr Pharmacol Ther. 2021. https:\/\/doi.org\/10.5863\/1551-6776-26.6.565.","DOI":"10.5863\/1551-6776-26.6.565"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-022-00771-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-022-00771-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-022-00771-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T07:08:30Z","timestamp":1670224110000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-022-00771-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,5]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["771"],"URL":"https:\/\/doi.org\/10.1186\/s12969-022-00771-x","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,5]]},"assertion":[{"value":"9 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"112"}}